Fig. 2From: Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort studyLocations of accepted study sites. As of November 30, 2015, there were 169 accepted study sites in the United States and Puerto Rico, including academic, community, and government sitesBack to article page